Expression of tumor suppressor REIC/Dkk-3 by a newly improved adenovirus vector with insertion of a hTERT promoter at the 3'-side of the transgene
I. Ruma
Oncology Letters, 2017
View PDFchevron_right
A novel gene expression system strongly enhances the anticancer effects of a REIC/Dkk-3-encoding adenoviral vector
Kazuhiko Ochiai, Jun-ichiro Futami, Masakiyo Sakaguchi
Oncology Reports, 2013
View PDFchevron_right
Transduction and Oncolytic Profile of a Potent Replication-Competent Adenovirus 11p Vector (RCAd11pGFP) in Colon Carcinoma Cells
Jim Silver
PLoS ONE, 2011
View PDFchevron_right
In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase
David Kerr
Gene Therapy, 2001
View PDFchevron_right
Principles and applications of gene therapy in colon cancer
Alexander Seifalian
Journal of Gastrointestinal and Liver Diseases Jgld, 2008
View PDFchevron_right
Results of retroviral and adenoviral approaches to cancer gene therapy
Richard Cote
STEM CELLS, 2009
View PDFchevron_right
Transduction of hepatocellular carcinoma (HCC) using recombinant adeno-associated virus (rAAV): in vitro and in vivo effects of genotoxic agents
Miguel Barajas
Journal of Hepatology, 2000
View PDFchevron_right
Data from A Novel A33 Promoter–Based Conditionally Replicative Adenovirus Suppresses Tumor Growth and Eradicates Hepatic Metastases in Human Colon Cancer Models
Cecilia Carbone
2023
View PDFchevron_right
Combined therapy of colon carcinomas with an oncolytic adenovirus and valproic acid
Wael Jdey
Oncotarget
View PDFchevron_right
Development of recombinant adeno-associated virus and adenovirus cocktail system for efficient hTERTC27 polypeptide-mediated cancer gene therapy
Hong Yao
Cancer Gene Therapy, 2008
View PDFchevron_right
Recombinant adenoassociated virus in cancer gene therapy
Jayanta Roy-Chowdhury
Journal of Hepatology, 2000
View PDFchevron_right
Antitumor Effects of Systemically Delivered Adenovirus Harboring Trans-Splicing Ribozyme in Intrahepatic Colon Cancer Mouse Model
HH Seo
Clinical Cancer Research, 2008
View PDFchevron_right
Modified adenoviruses for cancer gene therapy
Anna Kanerva
International journal of cancer. Journal international du cancer, 2004
View PDFchevron_right
Neoplastic Reversion Accomplished by High Efficiency Adenoviral-mediated Delivery of an Anti-ras Ribozyme
Jessi Cabrera
1995
View PDFchevron_right
Radiation increases the activity of oncolytic adenovirus cancer gene therapy vectors that overexpress the ADP (E3-11.6K) protein
Han Kim
Cancer Gene Therapy, 2003
View PDFchevron_right
Adeno-associated Virus for Cancer Gene Therapy1
Gene Siegal
2001
View PDFchevron_right
Improvement of Antitumor Activity by Gene Amplification with a Replicating but Nondisseminating Adenovirus
Bernard Massie
Cancer Research, 2007
View PDFchevron_right
Adenovirus-Mediated Drug-Sensitivity Gene Therapy for Hepatocellular Carcinoma
Paola Marignani
Hepatocellular Carcinoma, 2000
View PDFchevron_right
A Novel A33 Promoter-Based Conditionally Replicative Adenovirus Suppresses Tumor Growth and Eradicates Hepatic Metastases in Human Colon Cancer Models
Cecilia Carbone
Clinical Cancer Research, 2009
View PDFchevron_right
Gene Therapy for Pancreatic Cancer Targeting the Genomic Alterations of Tumor Suppressor Genes using Replication-selective Oncolytic Adenovirus
Akira Horii
Human Cell, 2002
View PDFchevron_right
Gene therapy strategies for colon cancer
David Kerr
Molecular Medicine Today, 2000
View PDFchevron_right
Cancer Gene Therapy- Developments and Future Perspectives
Jozef ANNE
Gene Therapy - Developments and Future Perspectives, 2011
View PDFchevron_right
Adeno-associated virus for cancer gene therapy
Gene Siegal
Cancer research, 2001
View PDFchevron_right
Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer
Masayoshi Kobune
Cancer Gene Therapy, 2003
View PDFchevron_right
Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vector
Gary Reynolds
View PDFchevron_right
Increased suppression of oncolytic adenovirus carrying mutant k5 on colorectal tumor
Tian Xiao
Biochemical and Biophysical Research Communications, 2008
View PDFchevron_right
Enhanced tumor suppressor gene therapy via replication-deficient adenovirus vectors expressing an N-terminal truncated retinoblastoma protein
Shi-xue Hu
Cancer research, 1996
View PDFchevron_right
Anti-Cancer Effects of REIC/Dkk-3-encoding Adenoviral Vector for the Treatment of Non-small Cell Lung Cancer
Shinichiro Miyoshi, Hiromi Kumon, Y. Nasu, Norimitsu Tanaka
PLoS ONE, 2014
View PDFchevron_right
Telomerase-dependent oncolytic adenovirus for cancer treatment
tiangui huang
Gene Therapy, 2003
View PDFchevron_right
Adenoviral vectors—How to use them in cancer gene therapy?
Andreja Ristov
Virus Research, 2006
View PDFchevron_right
Promoter-controlled infectivity-enhanced conditionally replicative adenoviral vectors for the treatment of gastric cancer
Koichi Takayama
Journal of Gastroenterology, 2005
View PDFchevron_right
International Society for Cell and Gene Therapy of Cancer: 2005 meeting in Shenzhen, China
James Norris
Cancer Gene Therapy, 2007
View PDFchevron_right
Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma
Manuel Caruso
Proceedings of the National Academy of Sciences of the United States of America, 1996
View PDFchevron_right
Antisense gene therapy using anti-k-ras and antitelomerase oligonucleotides in colorectal cancer
Salvador Aliño
Revista Española de Enfermedades Digestivas, 2005
View PDFchevron_right
Gene therapy for esophageal carcinoma: the use of an explant model to test adenoviral vectors ex vivo
Piter Bosma
Cancer Gene Therapy, 2004
View PDFchevron_right